These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 4790654)

  • 1. [Role of thyrocalcitonin in osteogenesis].
    Briskin AI
    Ortop Travmatol Protez; 1973 Dec; 34(12):69-71. PubMed ID: 4790654
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thyrocalcitonin in the picture of calcium homeostasis: physiopathological aspects and prospects of its therapeutic use].
    Chiarini P; Matassi L
    Clin Ter; 1972 Apr; 61(6):67-76. PubMed ID: 4340351
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium shift into bone: a calcitonin-resistant primary action of parathyroid hormone, studied in rats.
    Robinson CJ; Rafferty B; Parsons JA
    Clin Sci; 1972 Feb; 42(2):235-41. PubMed ID: 5058577
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of thyrocalcitonin and phosphate ion on the parathyroid hormone stimulated resorption of bone.
    Brand JS; Raisz LG
    Endocrinology; 1972 Feb; 90(2):479-87. PubMed ID: 5009332
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of porcine calcitonin on calcium metabolism in osteoporosis.
    Cohn SH; Dombrowski W; Hauser W; Klopper J; Atkins HL
    J Clin Endocrinol Metab; 1971 Nov; 33(5):719-28. PubMed ID: 5166454
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of thyrocalcitonin and parathyroid hormone of bone metabolism in tissue culture. Metabolism of bone in tissue culture: the effects of parathyroid hormone and thyrocalcitonin on the process of bone demineralization.
    Heersche JN
    Proc K Ned Akad Wet C; 1969; 72(5):594-606. PubMed ID: 4243855
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effects of phosphate and thyrocalcitonin on skeletal turnover.
    Haddad JG; Avioli LV
    Endocrinology; 1970 Dec; 87(6):1245-50. PubMed ID: 5482702
    [No Abstract]   [Full Text] [Related]  

  • 8. Involutional osteoporosis.
    Riggs BL; Melton LJ
    N Engl J Med; 1986 Jun; 314(26):1676-86. PubMed ID: 3520321
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
    Jowsey J; Riggs BL; Goldsmith RS; Kelly PJ; Arnaud CD
    J Clin Endocrinol Metab; 1971 Nov; 33(5):752-8. PubMed ID: 4942159
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of thyrocalcitonin and parathyroid hormone on bone metabolism in tissue culture. The effect on collagen breakdown in relation to bone demineralization.
    Heersche JN
    Proc K Ned Akad Wet C; 1969; 72(3):286-98. PubMed ID: 4240835
    [No Abstract]   [Full Text] [Related]  

  • 11. [Periosteocyte osteolysis in experimental hyperparathyroidism induced by EDTA; influence of calcitonin].
    Porte J; Meunier P; Bernard J; Roche M
    Pathol Biol (Paris); 1972 Oct; 20(19):775-9. PubMed ID: 4628423
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic studies with porcine calcitonin in osteoporosis.
    Brown P; Thin CG; Malone DN; Roscoe P; Strong JA
    Scott Med J; 1970 Jun; 15(6):207-12. PubMed ID: 5427158
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of parathyroid extract on the metabolism of ribonucleic acids in cultivated bone tissue. The parathyroid-hormone-induced stimulation of the uridine incorporation into the pool of RNA precursors and its inhibition by thyrocalcitonin.
    Van Wermeskerken RK
    Proc K Ned Akad Wet C; 1969; 72(5):623-36. PubMed ID: 4243857
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escape from inhibition or resorption in cultures of fetal bone treated with calcitoninand parathyroid hromone.
    Wener JA; Gorton SJ; Raisz LG
    Endocrinology; 1972 Mar; 90(3):752-9. PubMed ID: 4333146
    [No Abstract]   [Full Text] [Related]  

  • 16. Skeletal renewal and metabolic bone disease.
    Harris WH; Heaney RP
    N Engl J Med; 1969 Jan; 280(5):253-9 contd. PubMed ID: 4883109
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic and biochemical considerations of bone.
    Lutwak L
    Ann Clin Lab Sci; 1975; 5(3):185-94. PubMed ID: 166601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcitonin--thyrocalcitonin, hormone of the ultimobranchial body].
    Perraro F
    Folia Endocrinol; 1969 Apr; 22(2):119-65. PubMed ID: 4907630
    [No Abstract]   [Full Text] [Related]  

  • 19. The induction and inhibition of bone resorption in vitro.
    Reynolds JJ; Dingle JT
    Calcif Tissue Res; 1968; ():Suppl:50-50a. PubMed ID: 5721074
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of serum on the calcitonin-dependent bone resorption in vitro.
    Gozariu L; Bellwinkel S; Ziegler R
    Endocrinol Exp; 1973; 7(2):129-32. PubMed ID: 4541072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.